Drug Therapy
News
New ASAM guideline released amid COVID-19 concerns
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based...
Conference Coverage
Advances in ankylosing spondylitis hailed as rheumatology’s story of the year
MAUI, HAWAII – The likely approval of oral JAK inhibitors is predicted to transform the AS treatment paradigm.
News
Pembro ups survival in NSCLC: ‘Really extraordinary’ results
The 3-year overall survival rate was 35% in the entire cohort and 99% in patients who completed all treatment cycles.
FDA/CDC
FDA approves new drug for relapsed/refractory multiple myeloma
News
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
Among its many recommendations, the guideline strongly advises that women with RMD considering pregnancy switch to pregnancy‐compatible medication...
Conference Coverage
Cancer increase observed in modern era of MS drugs
WEST PALM BEACH, FLA. – The increased incidence is observed post 1996; the risk is nevertheless called small.
FDA/CDC
FDA OKs first orally disintegrating agent for rapid migraine relief
This is the first CGRP receptor antagonist available in a fast-acting orally disintegrating tablet for the acute treatment of migraine in adults...
News
Endocrine Society advises on use of romosozumab for osteoporosis
The update to the 2019 guideline specifies which postmenopausal women should, and should not, receive the drug.
News
FDA, FTC uniting to promote biosimilars
As part of their collaboration, the two agencies will be sponsoring a public workshop on March 9 to discuss...
FDA/CDC
FDA approves first IV migraine prevention drug
“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine...